Early Diagnosis of Lung Cancer

The incidence of lung cancer remains high, and smoking among women and young people is still on the increase; lung cancer prognosis is still poor, and it remains the number one cause of all cancer deaths. Moreover, this bleak prognosis is intimately linked to diagnosis all too often being made at an advanced incurable stage, with early diagnosis being so infrequent. However, lung cancer stage I survival at five years may reach more than 90%. Given this, we have two primary weapons to fight this unfavorable prognosis: prevention and early diagnosis. Governments worldwide have passed stringent smoking laws to prevent the incidence of lung cancer, involving outright bans and restricting smoke exposure in closed environments. Although this policy is universally supported, the increased proportion of teenage smokers, plus alternatives such as e-cigarettes, is likely to frustrate all the efforts implemented so far. The scientific community has a compelling impetus to strive towards a single test or a multipanel diagnostic algorithm for screening and detection of lung cancers at an early stage. Finally, industrialized countries are called upon to finance measures to improve precision medicine ranging from morphological imaging/CT/RMN to onco-multi-omics approaches, bearing in mind their lower invasiveness and greater portability.

Dr. Gasparri Roberto
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Early diagnosis of lung cancer
• Big data
• OMICS
• Chest CT scan and RMN whole-body